Health AI Central
Share:
Peer-Reviewed Publication
Addict Behav2019;98106016.November 1, 2019Journal Article

Factors associated with potentially problematic opioid prescriptions among individuals with private insurance and medicaid.

Mir M Ali1, Ali B Tehrani2, Ryan Mutter3, Rachel Mosher Henke4, Eli Cutler5, Jesse M Pines6, Maryann Mazer-Amirshahi7
1Office of the Assistant Secretary for Planning & Evaluation, US Department of Health & Human Services, 200 Independence Avenue SW, Washington, DC 20201, United States of America. Electronic address: ali.mir.m@gmail.com.
2Janssen Pharmaceutical Companies of Johnson & Johnson, United States of America.
3Health, Retirement and Long-Term Analysis Division, Congressional Budget Office, United States of America.
4IBM Watson Health, United States of America.
5Qventus, United States of America.
6US Acute Care Solutions, United States of America.
7MedStar Washington Hospital Center, United States of America.
PubMed DOI

Abstract

If opioid analgesics are prescribed and used inappropriately, they can lead to addiction and other adverse effects. In this study, we (1) examine factors associated with potentially problematic opioid prescriptions and (2) quantify the link between potentially problematic prescriptions and the development of opioid use disorder. We found that older age; female sex; having back pain, arthritis, or…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.